Gopinath Kasetty Selected Research

Roflumilast

4/2016

Roflumilast Increases Bacterial Load and Dissemination in a Model of Pseudomononas Aeruginosa Airway Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gopinath Kasetty Research Topics

Disease

12	Infections 01/2018 - 09/2010
5	Inflammation (Inflammations) 01/2019 - 01/2012
5	Shock 01/2016 - 01/2011
4	Bacterial Infections (Bacterial Infection) 12/2019 - 01/2016
4	Sepsis (Septicemia) 01/2016 - 01/2012
3	Cystic Fibrosis (Mucoviscidosis) 01/2018 - 01/2017
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2017 - 01/2016
3	Wounds and Injuries (Trauma) 01/2015 - 09/2010
2	Pseudomonas Infections 01/2016 - 01/2014
2	Rupture 09/2012 - 04/2011
1	Asthma (Bronchial Asthma) 01/2019
1	Lung Injury 01/2019
1	Transfusion-Related Acute Lung Injury 01/2019
1	Pneumococcal Infections 01/2019
1	Acute Lung Injury 01/2019
1	Gram-Negative Bacterial Infections 01/2018
1	Pneumonia (Pneumonitis) 01/2017
1	Neoplasms (Cancer) 01/2016
1	Septic Shock (Toxic Shock Syndrome) 01/2016
1	Atopic Dermatitis (Atopic Eczema) 12/2011
1	Leg Ulcer 09/2010

Drug/Important Bio-Agent (IBA)

10	Peptides (Polypeptides)IBA 01/2018 - 01/2011
4	OsteopontinIBA 01/2019 - 01/2016
3	EndotoxinsIBA 01/2018 - 01/2012
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 01/2014
3	Thrombin FDA Link 01/2015 - 06/2011
3	CytokinesIBA 01/2014 - 12/2011
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2016
2	LipopolysaccharidesIBA 01/2019 - 01/2011
2	tissue-factor-pathway inhibitor 2 (PP5)IBA 01/2018 - 01/2016
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2018 - 09/2010
2	Liposomes (Liposome)IBA 09/2012 - 04/2011
1	AntithrombinsIBA 12/2019
1	Protein Isoforms (Isoforms)IBA 12/2019
1	Chemotactic FactorsIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	AllergensIBA 01/2019
1	Histones (Histone)IBA 01/2019
1	von Willebrand FactorIBA 01/2018
1	AntigensIBA 01/2018
1	CollagenIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	EM703IBA 01/2017
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2017
1	Deoxyribonucleases (DNase)FDA Link 01/2017
1	LactamsIBA 01/2017
1	QuinolonesIBA 01/2017
1	MacrolidesIBA 01/2017
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 04/2016
1	RoflumilastIBA 04/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	Thromboplastin (Tissue Factor)IBA 01/2016
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 01/2016
1	CoagulantsIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	EpitopesIBA 01/2016
1	Antimicrobial PeptidesIBA 01/2016
1	Biocompatible Materials (Biomaterials)IBA 01/2015
1	Heparin Cofactor IIIBA 01/2014
1	Membrane LipidsIBA 09/2012
1	Antimicrobial Cationic PeptidesIBA 01/2012
1	FibrinIBA 01/2012
1	Thymic Stromal LymphopoietinIBA 12/2011
1	1,2-oleoylphosphatidylcholine (DOPC)IBA 04/2011
1	dioleoyl phosphatidylethanolamineIBA 04/2011
1	Phospholipids (Phosphatides)FDA LinkGeneric 04/2011
1	CholesterolIBA 04/2011
1	LipidsIBA 04/2011
1	1,2- dioleoyl- sn- glycero- 3- phosphoglycerol (DOPG)IBA 04/2011

Therapy/Procedure

1	Blood Transfusion (Blood Transfusions) 01/2019
1	Therapeutics 01/2019